Caminhos de cuidados de saúde das mulheres que consomem cocaína e/ou cannabis durante a gravidez. Estudo de coorte retrospectivo, La Pampa, Argentina
DOI:
https://doi.org/10.31053/1853.0605.v77.n2.26838Palavras-chave:
cocaína, cannabis, gravidez, atenção à saúde, hospitalizaçãoResumo
Introdução: o uso de cocaína e cannabis durante a gravidez é um problema crescente, de importância para a Saúde Pública Mundial.Mulheres consumidoras podem apresentar uma ampla gama de complicações durante a gravidez e os perinatais, embora o conhecimento sobre sua
evolução subsequente seja escasso. Objetivos: descrever as trajetórias de saúde de mulheres consumidoras de cocaína e/ou cannabis durante a gravidez
e compará-las com mulheres não-consumidoras. Métodos: estudo de coorte retrospectivo com grupo de comparação composto por 2 mulheres não
consumidoras para cada consumidor. Consumidores de mulheres foram detectados no Serviço de Neonatologia de um hospital público com um estudo
em urina pós-parto positivo para cocaína e / ou cannabis, entre 2009 e 2013. Resultados: 29 mulheres consumidoras foram avaliadas e 58 não-consumidoras.
No primeiro grupo, 93% das mulheres eram policonsumidores. Mulheres consumidoras apresentaram maior frequência de: histórico de violência em
suas infâncias (p <0,001), consultas prévias (p <0,0045) e adquiridas (p <0,0007), consultas médicas (p <0,0001) e consultas odontológicas (p = 0,0002)
emergência, hospitalizações (p <0,0001), e mortes violentas em parentes, comparando com não-consumidores.
Conclusões: mulheres que consomem cocaína e / ou cannabis durante a gestação tiveram menor freqüência em consulta agendada, maior número de
consultas médicas e odontológicas de emergência, de internação, e mortes. As lesões foram a principal causa de consulta e hospitalização. Nas variáveis
avaliadas, as diferenças entre consumidores e não consumidores de gravidez foram significativos.
Downloads
Não há dados estatísticos.
Referências
1. Chang JC, Holland CL, Tarr JA, “et al”. Perinatal Illicit Drug and Marijuana Use: An Observational Study Examining Prevalence, Screening, and Disclosure. American journal of health promotion: AJHP. 2017;31(1):35-42.
2. Chiandetti A, Hernandez G, Mercadal-Hally M, “et al”. Prevalence of prenatal exposure to substances of abuse: questionnaire versus biomarkers. Reproductive Health. 2017;14:137.
3. Roca Comas A, Vila Domènech JS, Massa Solé J, “et al” Prevalence of illicit drug use at the end of pregnancy: a cross-sectional study at the time of birth. Minerva Pediatr. 2017 Feb 7. doi: 10.23736/S0026-4946.17.04664-3.
4. Magri R, Míguez H, Parodi V, “et al”. Consumo de alcohol y otras drogas en embarazadas. Arch. Pediatr. Urug. 2007;78( 2 ): 122-132.
5. Villarreal Marina, Ré Silvina. Detección de drogas ilícitas en la orina en el Servicio de Neonatología, Hospital Molas. Arch. argent. pediatr. 2013;111(3): 232-236.
6. García- Algar O, Vall Combelles O, Puig Solab C, Mur Sierra A, Scaravellid G, Pacificie G, Monleón Getino T, Pichinie S. Exposición prenatal a drogas de abuso a través del análisis de meconio en una población de bajo nivel socioeconómico en Barcelona. An Pediatr (Barc). 2009;70(2):151–158.
7. Goel N, Beasley D, Rajkumar V, “et al”. Perinatal outcome of illicit substance abuse in pregnancy-comparative and temporary socio-clinical profile in the UK. Eur J Pediatr 2011;170(2):199-205.
8. Garcia Garcia J, Campistol Mas E, López-Vilchez MÁ, “et al”. Analysis of prenatal abuse in catalonia between the years 2011 and 2014. An Pediatr (Barc). 2018;88(3):150-159
9.Onah MN, Field S, van Heyningen T, “et al”. Predictors of alcohol and other drug use among pregnant women in a peri-urban South African setting. International Journal of Mental Health Systems. 2016;10:38..
10. Rocha P, Britto e Alves MT, Chagas D, “et al”. Prevalência e fatores associados ao uso de drogas ilícitas em gestantes da coorte BRISA. Cad. Saúde Pública. 2016; 32(1): e00192714.
11. Serino D, Peterson BS, Rosen TS. Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood. J Dual Diagn. 2018; Apr 25:0. doi: 10.1080/15504263.2018.1468946.
12. Oga EA, Mark K, Coleman-Cowger VH. Cigarette Smoking Status and Substance Use in Pregnancy. Matern Child Health J. 2018; Jun 7. doi: 10.1007/s10995-018-2543-9.
13. Proctor LJ, Lewis T, Roesch S, “et al”. Child maltreatment and age of alcohol and marijuana initiation in high-risk youth. Addict Behav. 2017;75:64-69.
14. Gunn JKL, Rosales CB, Center KE, “et al”. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 2016;6:e009986. doi:10.1136/bmjopen-2015- 009986.
15. Bonello MR, Xu F, Li Z, “et al”. Mental and Behavioral Disorders Due to Substance Abuse and Perinatal Outcomes: A Study Based on Linked Population Data in New South Wales, Australia. International Journal of Environmental Research and Public Health 2014;11(5):4991-5005.
16. Forray A, Merry B, Lin H, “et al”. Perinatal Substance Use: A Prospective Evaluation of Abstinence and Relapse. Drug and alcohol dependence. 2015;150:147-155
17. Villarreal M, Belmonte V, Abdala A, Olivares JL. Trayectorias sanitarias durante 4 años de niños expuestos prenatalmente a cocaína y/o cannabis. Estudio de cohorte retrospectivo en La Pampa, Argentina. Arch Argent Pediatr 2019;117(6):360-367. Disponible en: https://www.sap.org.ar/uploads/archivos/general/files_ao_villarrealpdf_1570479951.pdf
18. Kendler KS, Ohlsson H, Svikis DS, “et al”. The Protective Effect of Pregnancy on Risk for Drug Abuse: A Population, Co-relative, Co-spouse, and Within-Individual Analysis. Am J of Psychiatry. 2017;174(10):954-962.
19. Coleman-Cowger VH, Oga E, Peters EN, Mark K. Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy. Neurotoxicol Teratol. 2018;68:84-90.
20. Alvarez-Alonso MJ, Jurado-Barba R, Martínez-Martín N, “et al”. Association between maltreatment and polydrug use among adolescents. Child Abuse & Neglect. 2016;51:379-389.
21. Mills, R., Kisely, S., Alati, R., “et al”. Child maltreatment and cannabis use in young adulthood: a birth cohort study. Addiction 2017; 112(3):494–501.
22. Mendoza-Meléndez MÁ, Cepeda A, Frankeberger J “et al”. History of child sexual abuse among women consuming illicit substances in Mexico City. J Subst Use. 2018;23(5):520–527.
23. Johri M, Morales RE, Boivin J-F, “et al”. Increased risk of miscarriage among women experiencing physical or sexual intimate partner violence during pregnancy in Guatemala City, Guatemala: cross-sectional study. BMC Pregnancy and Childbirth. 2011;11:49.
24. Martin SL, Beaumont JL, Kupper LL. Substance use before and during pregnancy: links to intimate partner violence. Am J Drug Alcohol Abuse. 2003;29(3):599–617.
25. Olley BO, Seedat S, Gxamza F “et al”. Determinants of unprotected sex among HIV-positive patients in South Africa. AIDS Care. 2005;17(1):1–9.
26. Choenni V, Hammink A, van de Mheen D. Association Between Substance Use and the Perpetration of Family Violence in Industrialized Countries: A Systematic Review. Trauma Violence Abuse. 2017;18(1):37-50.
27. Oliveira TA, Bersusa AA, Santos TF, “et al”. Perinatal Outcomes in Pregnant Women Users of Illegal Drugs. Rev Bras Ginecol Obstet. 2016;38(4):183-8.
28. De Macêdo VC, de Lira PIC, de Frias PG, “et al”. Risk factors for syphilis in women: case-control study. Revista de Saúde Pública. 2017;51:78.
29. Babatunde VD, Menendez ME, Ring D. Does Illicit Drug Use Influence Inpatient Adverse Events, Death, Length of Stay, and Discharge After Orthopaedic Trauma? J Surg Orthop Adv.2016; 25(1):41-8.
2. Chiandetti A, Hernandez G, Mercadal-Hally M, “et al”. Prevalence of prenatal exposure to substances of abuse: questionnaire versus biomarkers. Reproductive Health. 2017;14:137.
3. Roca Comas A, Vila Domènech JS, Massa Solé J, “et al” Prevalence of illicit drug use at the end of pregnancy: a cross-sectional study at the time of birth. Minerva Pediatr. 2017 Feb 7. doi: 10.23736/S0026-4946.17.04664-3.
4. Magri R, Míguez H, Parodi V, “et al”. Consumo de alcohol y otras drogas en embarazadas. Arch. Pediatr. Urug. 2007;78( 2 ): 122-132.
5. Villarreal Marina, Ré Silvina. Detección de drogas ilícitas en la orina en el Servicio de Neonatología, Hospital Molas. Arch. argent. pediatr. 2013;111(3): 232-236.
6. García- Algar O, Vall Combelles O, Puig Solab C, Mur Sierra A, Scaravellid G, Pacificie G, Monleón Getino T, Pichinie S. Exposición prenatal a drogas de abuso a través del análisis de meconio en una población de bajo nivel socioeconómico en Barcelona. An Pediatr (Barc). 2009;70(2):151–158.
7. Goel N, Beasley D, Rajkumar V, “et al”. Perinatal outcome of illicit substance abuse in pregnancy-comparative and temporary socio-clinical profile in the UK. Eur J Pediatr 2011;170(2):199-205.
8. Garcia Garcia J, Campistol Mas E, López-Vilchez MÁ, “et al”. Analysis of prenatal abuse in catalonia between the years 2011 and 2014. An Pediatr (Barc). 2018;88(3):150-159
9.Onah MN, Field S, van Heyningen T, “et al”. Predictors of alcohol and other drug use among pregnant women in a peri-urban South African setting. International Journal of Mental Health Systems. 2016;10:38..
10. Rocha P, Britto e Alves MT, Chagas D, “et al”. Prevalência e fatores associados ao uso de drogas ilícitas em gestantes da coorte BRISA. Cad. Saúde Pública. 2016; 32(1): e00192714.
11. Serino D, Peterson BS, Rosen TS. Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood. J Dual Diagn. 2018; Apr 25:0. doi: 10.1080/15504263.2018.1468946.
12. Oga EA, Mark K, Coleman-Cowger VH. Cigarette Smoking Status and Substance Use in Pregnancy. Matern Child Health J. 2018; Jun 7. doi: 10.1007/s10995-018-2543-9.
13. Proctor LJ, Lewis T, Roesch S, “et al”. Child maltreatment and age of alcohol and marijuana initiation in high-risk youth. Addict Behav. 2017;75:64-69.
14. Gunn JKL, Rosales CB, Center KE, “et al”. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 2016;6:e009986. doi:10.1136/bmjopen-2015- 009986.
15. Bonello MR, Xu F, Li Z, “et al”. Mental and Behavioral Disorders Due to Substance Abuse and Perinatal Outcomes: A Study Based on Linked Population Data in New South Wales, Australia. International Journal of Environmental Research and Public Health 2014;11(5):4991-5005.
16. Forray A, Merry B, Lin H, “et al”. Perinatal Substance Use: A Prospective Evaluation of Abstinence and Relapse. Drug and alcohol dependence. 2015;150:147-155
17. Villarreal M, Belmonte V, Abdala A, Olivares JL. Trayectorias sanitarias durante 4 años de niños expuestos prenatalmente a cocaína y/o cannabis. Estudio de cohorte retrospectivo en La Pampa, Argentina. Arch Argent Pediatr 2019;117(6):360-367. Disponible en: https://www.sap.org.ar/uploads/archivos/general/files_ao_villarrealpdf_1570479951.pdf
18. Kendler KS, Ohlsson H, Svikis DS, “et al”. The Protective Effect of Pregnancy on Risk for Drug Abuse: A Population, Co-relative, Co-spouse, and Within-Individual Analysis. Am J of Psychiatry. 2017;174(10):954-962.
19. Coleman-Cowger VH, Oga E, Peters EN, Mark K. Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy. Neurotoxicol Teratol. 2018;68:84-90.
20. Alvarez-Alonso MJ, Jurado-Barba R, Martínez-Martín N, “et al”. Association between maltreatment and polydrug use among adolescents. Child Abuse & Neglect. 2016;51:379-389.
21. Mills, R., Kisely, S., Alati, R., “et al”. Child maltreatment and cannabis use in young adulthood: a birth cohort study. Addiction 2017; 112(3):494–501.
22. Mendoza-Meléndez MÁ, Cepeda A, Frankeberger J “et al”. History of child sexual abuse among women consuming illicit substances in Mexico City. J Subst Use. 2018;23(5):520–527.
23. Johri M, Morales RE, Boivin J-F, “et al”. Increased risk of miscarriage among women experiencing physical or sexual intimate partner violence during pregnancy in Guatemala City, Guatemala: cross-sectional study. BMC Pregnancy and Childbirth. 2011;11:49.
24. Martin SL, Beaumont JL, Kupper LL. Substance use before and during pregnancy: links to intimate partner violence. Am J Drug Alcohol Abuse. 2003;29(3):599–617.
25. Olley BO, Seedat S, Gxamza F “et al”. Determinants of unprotected sex among HIV-positive patients in South Africa. AIDS Care. 2005;17(1):1–9.
26. Choenni V, Hammink A, van de Mheen D. Association Between Substance Use and the Perpetration of Family Violence in Industrialized Countries: A Systematic Review. Trauma Violence Abuse. 2017;18(1):37-50.
27. Oliveira TA, Bersusa AA, Santos TF, “et al”. Perinatal Outcomes in Pregnant Women Users of Illegal Drugs. Rev Bras Ginecol Obstet. 2016;38(4):183-8.
28. De Macêdo VC, de Lira PIC, de Frias PG, “et al”. Risk factors for syphilis in women: case-control study. Revista de Saúde Pública. 2017;51:78.
29. Babatunde VD, Menendez ME, Ring D. Does Illicit Drug Use Influence Inpatient Adverse Events, Death, Length of Stay, and Discharge After Orthopaedic Trauma? J Surg Orthop Adv.2016; 25(1):41-8.
Publicado
2020-05-10
Como Citar
1.
Villarreal M, Belmonte V, Olivares JL, Abdala A. Caminhos de cuidados de saúde das mulheres que consomem cocaína e/ou cannabis durante a gravidez. Estudo de coorte retrospectivo, La Pampa, Argentina. Rev Fac Cien Med Univ Nac Cordoba [Internet]. 10º de maio de 2020 [citado 30º de junho de 2024];77(2):79-85. Disponível em: https://revistas.unc.edu.ar/index.php/med/article/view/26838
Edição
Seção
Artículos Originales
Licença
La Revista de la Facultad de Ciencias Médicas de Córdoba (RFCM) adhiere a la política de Acceso Abierto y no cobra cargos a los autores para publicar, ni tampoco a lectores para acceder a los artículos publicados.
